NCT06780475View on ClinicalTrials.gov

Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell Carcinoma

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions

Merkel Cell Carcinoma of Skin

Trial Locations (1)

92100

Dermato-oncology Department, Ambroise Paré Hospital, APHP, Boulogne-Billancourt

All Listed Sponsors

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06780475 - Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell Carcinoma | Biotech Hunter | Biotech Hunter